BY
en
  • Custom development &
    Manufacturing
    Custom development &
    Manufacturing
    • Custom development &
      Manufacturing
    • Custom APIs
    • Custom Intermediates
  • Generic
    APIs
  • Consumer Health
    Care
  • Drug Delivery
    Solutions
    Drug Delivery
    Solutions
    • Drug Delivery
      Solutions
    • Smart Excipients & Polymers Catalog
    • Custom Lipids
    • Custom GMP Polymers
  • Catalog
    Offer
    Catalog
    Offer
    • Catalog
      Offer
    • Product Catalog of Generic APIs
    • Pre-GMP API / Intermediates Catalog
    • Smart Excipients & Polymers Catalog
Locations Products
  • Seqens Group
  • Careers
  • Newsroom
  • Contact
  • Seqens Group
  • Careers
  • Newsroom
  • Contact
en
Products
Our locations
  • Custom development &
    Manufacturing
    Custom development &
    Manufacturing
    • Custom APIs
    • Custom Intermediates
  • Generic
    APIs
  • Consumer Health
    Care
  • Drug Delivery
    Solutions
    Drug Delivery
    Solutions
    • Smart Excipients & Polymers Catalog
    • Custom Lipids
    • Custom GMP Polymers
  • Catalog
    Offer
    Catalog
    Offer
    • Product Catalog of Generic APIs
    • Pre-GMP API / Intermediates Catalog
    • Smart Excipients & Polymers Catalog
Top of page
Share

Proprietary API Intermediates

CDMO-seqens

Registered API Intermediates & Raw Materials

Using in-house biocatalysis technology, SEQENS has developed direct synthesis of D-Serine, as well as the full range of products in the ketamine family: Hydrochloride and free base, racemic and both chiral pure products, S-Ketamine and R-Ketamine.
Read more

Pre-GMP API / Intermediates Catalog

SEQENS offers a full range of proprietary intermediates (non-regulated, RSM and GMP), from our pre-GMP and GMP plants. We supply  pharma intermediates with a wide…
Read more

Join theSeqens teams!

Find out more

Subscribe to our newsletter

  • Home
  • Newsroom
  • Privacy policy
  • GTC

About SEQENS

Contact us

Contact us

Follow the seqens evolution on

social media

DISCOVER OUR NEWS

Learn more